Document is current
Any future updates will be listed below
-
Authors
Bandeira, Cibele E.
Grevet, Eugenio H.
Cupertino, Renata B.
Tavares, Maria E. de Araujo
Gusmão, Clara S.
Kappel, Djenifer B.
Vitola, Eduardo S.
Picon, Felipe A.
Rohde, Luís A.
da Silva, Bruna S.
Bau, Claiton H. D.
Rovaris, Diego L. https://orcid.org/0000-0002-8910-4927
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (466722/2014-1, 424041/2016-2, 426905/2016-4, 431472/2018-1, 140853/2019-7)
CAPES (001)
FIPE-HCPA (160600)
GPPG-HCPA (01-321)
- License Information
-
More Information
Article History
Received: 29 May 2021
Accepted: 23 September 2021
First Online: 5 October 2021
Declarations
:
: The authors declare the following potential conflict of interest: Dr. Grevet was on the speaker’s bureau for Novartis and Shire for three years. He also received travel awards (air tickets and hotel accommodations) for participating in two psychiatric meetings from Shire and Novartis. Dr. Rohde has been on the speakers’ bureau/advisory board or has acted as a consultant for Medice, Novartis/Sandoz, and Shire/Takeda in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He also received travel awards for taking part in the 2016 AACAP meeting from Novartis and the 2018 APA meeting from Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen-Cilag, Medice, Novartis/Sandoz, and Shire/Takeda. All other authors declare that they have no conflict of interest.
: This work was approved by the institutional review board of Hospital de Clínicas de Porto Alegre—HCPA (IRB 0000921)—Universidade Federal do Rio Grande do Sul, Brazil.
: Informed consent was obtained from all individual participants included in the study.
